ELEV vs. IDYA
Compare and contrast key facts about Elevation Oncology Inc (ELEV) and IDEAYA Biosciences, Inc. (IDYA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ELEV or IDYA.
Performance
ELEV vs. IDYA - Performance Comparison
Returns By Period
In the year-to-date period, ELEV achieves a 12.36% return, which is significantly higher than IDYA's -24.70% return.
ELEV
12.36%
0.47%
-84.29%
30.69%
N/A
N/A
IDYA
-24.70%
-9.19%
-28.96%
-15.22%
30.29%
N/A
Fundamentals
| ELEV | IDYA | |
|---|---|---|
| Market Cap | $34.29M | $2.24B |
| EPS | -$0.80 | -$2.30 |
| Total Revenue (TTM) | $58.00K | $3.92M |
| Gross Profit (TTM) | $29.00K | $720.00K |
| EBITDA (TTM) | -$40.62M | -$223.50M |
Key characteristics
| ELEV | IDYA | |
|---|---|---|
| Sharpe Ratio | 0.19 | -0.33 |
| Sortino Ratio | 1.81 | -0.18 |
| Omega Ratio | 1.26 | 0.98 |
| Calmar Ratio | 0.32 | -0.33 |
| Martin Ratio | 0.57 | -0.76 |
| Ulcer Index | 53.64% | 20.00% |
| Daily Std Dev | 164.08% | 46.07% |
| Max Drawdown | -97.64% | -74.64% |
| Current Drawdown | -96.25% | -43.16% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ELEV and IDYA is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
ELEV vs. IDYA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Elevation Oncology Inc (ELEV) and IDEAYA Biosciences, Inc. (IDYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ELEV vs. IDYA - Dividend Comparison
Neither ELEV nor IDYA has paid dividends to shareholders.
Drawdowns
ELEV vs. IDYA - Drawdown Comparison
The maximum ELEV drawdown since its inception was -97.64%, which is greater than IDYA's maximum drawdown of -74.64%. Use the drawdown chart below to compare losses from any high point for ELEV and IDYA. For additional features, visit the drawdowns tool.
Volatility
ELEV vs. IDYA - Volatility Comparison
Elevation Oncology Inc (ELEV) has a higher volatility of 26.18% compared to IDEAYA Biosciences, Inc. (IDYA) at 15.67%. This indicates that ELEV's price experiences larger fluctuations and is considered to be riskier than IDYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ELEV vs. IDYA - Financials Comparison
This section allows you to compare key financial metrics between Elevation Oncology Inc and IDEAYA Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities